NCT05445804View on ClinicalTrials.gov

Oral Cannabidiol for Tobacco Cessation

PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

December 1, 2025

Study Completion Date

February 1, 2026

Conditions
Tobacco UseTobacco SmokingTobacco DependenceTobacco Use DisorderTobacco Use Cessation
Interventions
DRUG

300 mg Cannabidiol

300 mg CBD in Medium Chain Triglyceride oil b.i.d.

DRUG

600 mg Cannabidiol

600 mg CBD in Medium Chain Triglyceride oil b.i.d.

DRUG

Placebo

Medium Chain Triglyceride oil

Trial Locations (1)

21224

RECRUITING

Johns Hopkins Behavioral Pharmacology Research Unit, Baltimore

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Johns Hopkins University

OTHER